The safety and efficacy of zotepine in the treatment of schizophrenia: Results of a one-year naturalistic clinical trial

International Journal of Psychiatry in Clinical Practice

Volumn 4, Issue 4, 2000, Pages 299-306

  Palmgren, K ^a   Wighton, A ^b   Reynolds, C W ^a   Butler, A ^b   Tweed, J A ^b   Raniwalla, J ^b   Welch, C P ^b   Bratty, J R ^a  

^a Ekasen Sjukhus   (Finland)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Efficacy; Long term; Maintenance; Schizophrenia; Zotepine

Indexed keywords

LIVER ENZYME; URIC ACID; ZOLEPTIL; ZOTEPINE;

ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEART RATE; HUMAN; LIVER FUNCTION TEST; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SEIZURE; SIDE EFFECT; URIC ACID BLOOD LEVEL; WEIGHT GAIN;

EID: 0034534018     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651500050517867     Document Type: Article

References (27)

1. The de facto US Mental and Addictive Disorders System: Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services
2. Economic outcomes and costs in the treatment of schizophrenia
3. Cost of relapse in schizophrenia
4. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
5. Treatment of schizophrenia
6. Compliance and outcome in patients treated with antipsychotics: The impact of extrapyramidal symptoms
7. Zotepine: Preclinical tests predict antipsychotic efficacy and an atypical profile
8. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
9. 2 receptors
10. Receptor interactions of new antipsychotics: Relation to pharmacodynamics and clinical effects
11. Elevation of extracellular cortical noradrenaline may contribute to the antidepressant activity of zotepine: An in vivo microdialysis study in freely-moving rats
12. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: A parallelgroup double-blind trial
13. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol
14. Zoterpine in the prevention of recurrence: A randomised, double blind placebo-controlled study for chronic schizophrenia
15. Introduction - The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling
16. The scale for the assessment of negative symptoms (SANS): Conceptual and theoretical foundation
17. A rating scale for extrapyramidal side effects
18. A rating scale for drug-induced akathisia
19. Zotepine vs haloperidol in paranoid schizophrenia
20. Efficacy and tolerance of zotepine in a double-blind comparison with perazine in schizophrenics
21. Clinical efficacy of zotepine in the treatment of schizophrenic negative systems